IBB vs. DBE
IBB (iShares Nasdaq Biotechnology ETF) and DBE (Invesco DB Energy Fund) are both exchange-traded funds - IBB is a Health & Biotech Equities fund tracking the NASDAQ Biotechnology Index, while DBE is a Oil & Gas fund tracking the DBIQ Optimum Yield Energy Index. Both are passively managed. Over the past 10 years, IBB returned 6.89%/yr vs 13.17%/yr for DBE. Their 0.15 correlation means their historical movements had little consistent relationship. IBB charges 0.47%/yr vs 0.78%/yr for DBE.
Performance
IBB vs. DBE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBB achieves a 10.55% return, which is significantly lower than DBE's 78.87% return. Over the past 10 years, IBB has underperformed DBE with an annualized return of 6.89%, while DBE has yielded a comparatively higher 13.17% annualized return.
IBB
- 1D
- -1.87%
- 1M
- -4.75%
- 6M
- 8.20%
- YTD
- 10.55%
- 1Y
- 40.47%
- 3Y*
- 13.65%
- 5Y*
- 2.65%
- 10Y*
- 6.89%
- ALL TIME*
- 7.16%
DBE
- 1D
- 1.13%
- 1M
- 21.13%
- 6M
- 53.89%
- YTD
- 78.87%
- 1Y
- 68.62%
- 3Y*
- 17.16%
- 5Y*
- 17.73%
- 10Y*
- 13.17%
- ALL TIME*
- 2.52%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.24M | $1.18M | $1.76M | |
| $252.83M | $308.82M | $278.87M |
IBB vs. DBE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 10.55% | 27.98% | -2.41% | 3.76% | -13.69% | 0.95% | 26.01% | 25.42% | -9.53% | 21.08% |
DBE Invesco DB Energy Fund | 78.87% | -2.17% | 2.96% | -12.14% | 33.77% | 57.56% | -25.91% | 19.72% | -12.95% | 5.21% |
Correlation
The correlation between IBB and DBE is -0.29, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.29 |
Correlation (3Y) Balances recent behavior with more history. | -0.15 |
Correlation (5Y) Shows whether the relationship held over a longer period. | -0.05 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.07 |
Correlation (All Time) Calculated using the full available price history since Jan 5, 2007 | 0.15 |
The correlation between IBB and DBE shifts across timeframes, from -0.29 (1 year) to 0.15 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBB vs. DBE — Risk / Return Rank
IBB
DBE
IBB vs. DBE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and Invesco DB Energy Fund (DBE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IBB | DBE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.29 | ||
| Sortino ratioReturn per unit of downside risk | +0.50 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.29 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 4.25 | 2.59 | +1.66 |
| Martin ratioReturn relative to average drawdown | 12.35 | 8.14 | +4.21 |
Loading charts...
Drawdowns
IBB vs. DBE - Drawdown Comparison
The maximum IBB drawdown since its inception was -62.85%, smaller than the maximum DBE drawdown of -86.69%. Use the drawdown chart below to compare losses from any high point for IBB and DBE.
Loading charts...
Drawdown Indicators
| IBB | DBE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.85% | -86.69% | +23.84% |
Max Drawdown (1Y)Largest decline over 1 year | -9.63% | -24.72% | +15.09% |
Max Drawdown (3Y)Largest decline over 3 years | -24.85% | -24.72% | -0.13% |
Max Drawdown (5Y)Largest decline over 5 years | -39.82% | -38.74% | -1.08% |
Max Drawdown (10Y)Largest decline over 10 years | -39.82% | -60.84% | +21.02% |
Current DrawdownCurrent decline from peak | -5.96% | -32.09% | +26.13% |
Average DrawdownAverage peak-to-trough decline | -21.06% | -57.13% | +36.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.31% | 8.15% | -4.84% |
Volatility
IBB vs. DBE - Volatility Comparison
The current volatility for iShares Nasdaq Biotechnology ETF (IBB) is 6.14%, while Invesco DB Energy Fund (DBE) has a volatility of 14.12%. This indicates that IBB experiences smaller price fluctuations and is considered to be less risky than DBE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBB | DBE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.14% | 14.12% | -7.98% |
Volatility (6M)Calculated over the trailing 6-month period | 15.87% | 33.95% | -18.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.45% | 37.47% | -17.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.12% | 30.09% | -7.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.12% | 28.58% | -5.46% |
IBB vs. DBE - Expense Ratio Comparison
IBB has a 0.47% expense ratio, which is lower than DBE's 0.78% expense ratio.
Dividends
IBB vs. DBE - Dividend Comparison
IBB's dividend yield for the trailing twelve months is around 0.22%, less than DBE's 2.16% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DBE Invesco DB Energy Fund | 2.16% | 3.86% | 6.32% | 3.87% | 0.75% | 0.00% | 0.00% | 1.79% | 1.67% | 0.00% | 0.00% | 0.00% |
IBB iShares Nasdaq Biotechnology ETF | 0.22% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
Frequently Asked Questions
IBB and DBE have a correlation of -0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DBE has higher volatility (14.12%) compared to IBB (6.14%). In terms of maximum drawdown, IBB dropped -62.85% vs DBE's -86.69%.
On 10-year performance, DBE leads with 13.17% vs 6.89% for IBB. On fees, IBB is cheaper at 0.47% per year. On volatility, IBB has been the lower-risk option at 6.14%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, DBE has performed better with a 13.17% return vs 6.89%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBB is cheaper with a 0.47% expense ratio, compared with 0.78% for DBE.
DBE has the higher dividend yield at 2.16%, compared with 0.22% for IBB.
IBB is categorized as Health & Biotech Equities, while DBE is Oil & Gas. IBB tracks NASDAQ Biotechnology Index, while DBE tracks DBIQ Optimum Yield Energy Index. They also come from different issuers: iShares and Invesco. Their fees differ too: 0.47% for IBB and 0.78% for DBE.
IBB currently has the higher Sharpe Ratio (2.00 vs 1.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBB and DBE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer